344 related articles for article (PubMed ID: 36279081)
1. Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light.
Zhang J; Wu K; Shi C; Li G
Curr Treat Options Oncol; 2022 Dec; 23(12):1777-1792. PubMed ID: 36279081
[TBL] [Abstract][Full Text] [Related]
2. A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics.
Zhang J; Dai Z; Yan C; Zhang W; Wang D; Tang D
Clin Transl Oncol; 2021 Dec; 23(12):2415-2430. PubMed ID: 34125407
[TBL] [Abstract][Full Text] [Related]
3. Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy.
Yang Y; An Y; Dong Y; Chu Q; Wei J; Wang B; Cao H
EBioMedicine; 2024 Feb; 100():104967. PubMed ID: 38241975
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment.
Xu H; Cao C; Ren Y; Weng S; Liu L; Guo C; Wang L; Han X; Ren J; Liu Z
Front Immunol; 2022; 13():949490. PubMed ID: 36177041
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota shed new light on the management of immune-related adverse events.
Tan B; Liu YX; Tang H; Chen D; Xu Y; Chen MJ; Li Y; Wang MZ; Qian JM
Thorac Cancer; 2022 Oct; 13(19):2681-2691. PubMed ID: 36043345
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
Lau HCH; Sung JJ; Yu J
Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
[TBL] [Abstract][Full Text] [Related]
8. Future indications and clinical management for fecal microbiota transplantation (FMT) in immuno-oncology.
Jamal R; Messaoudene M; de Figuieredo M; Routy B
Semin Immunol; 2023 May; 67():101754. PubMed ID: 37003055
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers.
McQuade JL; Ologun GO; Arora R; Wargo JA
Curr Oncol Rep; 2020 Jun; 22(7):74. PubMed ID: 32577835
[TBL] [Abstract][Full Text] [Related]
10. Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors.
Abenavoli L; Montori M; Svegliati Baroni G; Argenziano ME; Giorgi F; Scarlata GGM; Ponziani F; Scarpellini E
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629716
[No Abstract] [Full Text] [Related]
11. Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer.
Kang YB; Cai Y
World J Gastroenterol; 2021 Aug; 27(32):5362-5375. PubMed ID: 34539138
[TBL] [Abstract][Full Text] [Related]
12. DeepGeni: deep generalized interpretable autoencoder elucidates gut microbiota for better cancer immunotherapy.
Oh M; Zhang L
Sci Rep; 2023 Mar; 13(1):4599. PubMed ID: 36944780
[TBL] [Abstract][Full Text] [Related]
13. Incongruence between dominant commensal donor microbes in recipient feces post fecal transplant and response to anti-PD-1 immunotherapy.
Koo H; Morrow CD
BMC Microbiol; 2021 Sep; 21(1):251. PubMed ID: 34544375
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota in Cancer Immune Response and Immunotherapy.
Zhou CB; Zhou YL; Fang JY
Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
[TBL] [Abstract][Full Text] [Related]
15. Role of gut microbiome on immunotherapy efficacy in melanoma.
Bibbò S; Ianiro G; Giambò F; Settanni CR; Cammarota G; Gasbarrini A
Hum Vaccin Immunother; 2022 May; 18(3):1926759. PubMed ID: 34190675
[TBL] [Abstract][Full Text] [Related]
16. Interaction between gut microbiota and immune checkpoint inhibitor-related colitis.
Zhou G; Zhang N; Meng K; Pan F
Front Immunol; 2022; 13():1001623. PubMed ID: 36389768
[TBL] [Abstract][Full Text] [Related]
17. Role of the microbiota in response to and recovery from cancer therapy.
Blake SJ; Wolf Y; Boursi B; Lynn DJ
Nat Rev Immunol; 2024 May; 24(5):308-325. PubMed ID: 37932511
[TBL] [Abstract][Full Text] [Related]
18. Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial.
Borgers JSW; Burgers FH; Terveer EM; van Leerdam ME; Korse CM; Kessels R; Flohil CC; Blank CU; Schumacher TN; van Dijk M; Henderickx JGE; Keller JJ; Verspaget HW; Kuijper EJ; Haanen JBAG
BMC Cancer; 2022 Dec; 22(1):1366. PubMed ID: 36585700
[TBL] [Abstract][Full Text] [Related]
19. Complex interactions between the microbiome and cancer immune therapy.
Schwartz DJ; Rebeck ON; Dantas G
Crit Rev Clin Lab Sci; 2019 Dec; 56(8):567-585. PubMed ID: 31526274
[TBL] [Abstract][Full Text] [Related]
20. Intestinal microbiota: a new force in cancer immunotherapy.
Dai Z; Zhang J; Wu Q; Fang H; Shi C; Li Z; Lin C; Tang D; Wang D
Cell Commun Signal; 2020 Jun; 18(1):90. PubMed ID: 32522267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]